Differential efficacy of nicotine replacement among overweight and obese women smokers.
Introduction Rates of obesity are higher among more dependent smokers and 37-65% of smokers seeking cessation treatment are overweight or obese. Overweight or obese smokers may possess metabolic and neurobiological features that contribute to difficulty achieving cessation using front-line nicotine...
Main Authors: | Strong, DR, David, S, Johnstone, E, Aveyard, P, Murphy, M, Munafò, M |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2014
|
Registos relacionados
-
Effect on adherence to nicotine replacement therapy of informing smokers their dose is determined by their genotype: a randomised controlled trial.
Por: Marteau, T, et al.
Publicado em: (2012) -
Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial
Por: Munafo, M, et al.
Publicado em: (2009) -
Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial.
Por: Munafò, MR, et al.
Publicado em: (2009) -
Effect on adherence to nicotine replacement therapy of informing smokers their dose is determined by their genotype: a randomised controlled trial.
Por: Theresa M Marteau, et al.
Publicado em: (2012-01-01) -
Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement.
Por: Uhl, G, et al.
Publicado em: (2010)